AMT-029

N/A

Report date: 2025/01/26 17:12:52

Base Information

Drug NameAMT-029
Drug Alias NameAMT-029
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMultitude Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMultitude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A